Nurix Therapeutics, Inc. (NRIX)
26.27
-0.45
(-1.68%)
USD |
NASDAQ |
Aug 24, 16:00
26.35
+0.08
(+0.30%)
Pre-Market: 08:02
Nurix Therapeutics Market Cap : 2.724B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 2.724B |
| August 21, 2026 | 2.771B |
| August 20, 2026 | 2.805B |
| August 19, 2026 | 2.882B |
| August 18, 2026 | 2.793B |
| August 17, 2026 | 2.818B |
| August 14, 2026 | 2.805B |
| August 13, 2026 | 2.820B |
| August 12, 2026 | 2.762B |
| August 11, 2026 | 2.692B |
| August 10, 2026 | 2.684B |
| August 07, 2026 | 2.647B |
| August 06, 2026 | 2.615B |
| August 05, 2026 | 2.605B |
| August 04, 2026 | 2.560B |
| August 03, 2026 | 2.408B |
| July 31, 2026 | 2.407B |
| July 30, 2026 | 2.445B |
| July 29, 2026 | 2.447B |
| July 28, 2026 | 2.504B |
| July 27, 2026 | 2.430B |
| July 24, 2026 | 2.425B |
| July 23, 2026 | 2.462B |
| July 22, 2026 | 2.447B |
| July 21, 2026 | 2.435B |
| Date | Value |
|---|---|
| July 20, 2026 | 2.355B |
| July 17, 2026 | 2.398B |
| July 16, 2026 | 2.392B |
| July 15, 2026 | 2.473B |
| July 14, 2026 | 2.383B |
| July 13, 2026 | 2.355B |
| July 10, 2026 | 2.391B |
| July 09, 2026 | 2.560B |
| July 08, 2026 | 2.521B |
| July 07, 2026 | 2.530B |
| July 06, 2026 | 2.486B |
| July 02, 2026 | 2.478B |
| July 01, 2026 | 2.472B |
| June 30, 2026 | 2.508B |
| June 29, 2026 | 2.466B |
| June 26, 2026 | 2.368B |
| June 25, 2026 | 2.322B |
| June 24, 2026 | 1.996B |
| June 23, 2026 | 1.950B |
| June 22, 2026 | 1.928B |
| June 18, 2026 | 1.815B |
| June 17, 2026 | 1.770B |
| June 16, 2026 | 1.765B |
| June 15, 2026 | 1.762B |
| June 12, 2026 | 1.753B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Monte Rosa Therapeutics, Inc. | 1.174B |
| Gilead Sciences, Inc. | 182.10B |
| TG Therapeutics, Inc. | 8.574B |
| Cue Biopharma, Inc. | 121.22M |
| Keros Therapeutics, Inc. | 213.74M |
Market Cap Related Metrics
| PS Ratio | 71.52 |
| PEG Ratio | -0.2382 |
| Price to Book Value | 6.766 |
| Price | 26.27 |
| Earnings Yield | -13.12% |
| PEGY Ratio | -0.2382 |